Z-0441-2026 Class II Ongoing

Recalled by Beckman Coulter Inc. — Brea, CA

FDA device recall Z-0441-2026 was initiated by Beckman Coulter Inc. on Sep 17, 2025 and is designated Class II. Reason for recall: Beckman Coulter has identified that there is an increased probability Synchron Systems Direct LDL Cholesterol (LDLD REF 969706) reagent lot M404166 may generate false high results. The issue was… The recall status is ongoing. Affected quantity: 2,932 units.

Recall details

Product Type
Devices
Report Date
Nov 12, 2025
Initiation Date
Sep 17, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,932 units

Product description

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

Reason for recall

Beckman Coulter has identified that there is an increased probability Synchron Systems Direct LDL Cholesterol (LDLD REF 969706) reagent lot M404166 may generate false high results. The issue was discovered internally and confirmed on August 19, 2025 by Beckman Coulter.

Distribution pattern

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, GA, HI, IA, ID, KS, KY, LA, MA, MD, ME, MI, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, PR, QC, SC, TX, WA, WV and the country of Canada.

Code information

REF: 969706. Lot: M404166. Expiration Date: 30Nov2025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0441-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0441-2026. Report a data issue: hello@regdatalab.com.